Independent report

Prioritising the first COVID-19 vaccine dose: JCVI statement

Statement from the Joint Committee on Vaccination and Immunisation (JCVI) about increasing the short-term impact of the COVID-19 vaccination programme.

• From: Department of Health and Social Care
• Published: 6 January 2021
• Last updated: 26 January 2021 — See all updates

Documents

Optimising the COVID-19 vaccination programme for maximum short-term impact

HTML

Annex A: PHE report to JCVI on estimated efficacy of a single dose of Pfizer BioNTech (BNT162b2 mRNA) vaccine and of a single dose of ChAdOx1 vaccine (AZD1222)

PDF, 281 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Annex B: comparison between 1 and 2 dose prioritisation for a fixed number of doses

PDF, 357 KB, 7 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This statement sets out additional explanation on the advice of JCVI on extending the schedule for COVID-19 vaccines published on 30 December 2020.

Published 6 January 2021
Last updated 26 January 2021 + show all updates

1. 26 January 2021

   Added document 'Annex B: comparison between 1 and 2 dose prioritisation for a fixed number of doses'.

2. 6 January 2021

   First published.